Flu Vaccination Case

1492 Words6 Pages
Ethical Policy Analysis of the 2004 Flu Vaccine Shortage Politicians are often faced with making decisions that affect all citizens’ health and healthcare options. There are different ways that the situations are assessed and policies are made. Some of these decisions are based on an ethical analysis of the situation, while others are made out of greed and other political reason, and some are just made hastily without any real effort. An important question to consider is also how qualified these politicians are to make decisions on citizens’ health. Many policy failures could have been prevented with proper analysis of the situation and implementation of policies to protect the citizens. One of these cases is the flu vaccination…show more content…
Prudent pragmatism is a case based method and evolved casuistry. The beginnings of the case method can be traced back to Aristotle, who believed that “only through experience does a person become acquainted with the variety of circumstances that significantly color ethical choice. A novice has too little relevant material at hand to inform his or her choices.” (Bluhm & Heineman 2007, p. 28). If one look at the years leading up to the case in 2004, it is easy to see that a shortage of flu vaccinations is not new to the United States. In 2000 there was a vaccine shortage because quality control issues caused a 6-8 week delay in vaccine delivery. That year supplies were distributed unevenly and prices doubled as a cause of the perceived increase in demand. In 2001 only about two thirds of the produced doses were available at the beginning of the flu season. Then again in 2003 the amount of vaccine supplied did not meet the demand for vaccinations because 4 million doses were destroyed and 87 million were inappropriate for that season’s flu strain. Not taking any action in this case has proven to be a bad decision as was quickly learned in 2004. When analyzing the case using the prudent pragmatism method to develop policy recommendations, one may compare the current case to see what may have caused the situation to worsen. Over the years the amount of vaccine manufacturers in the U.S. has declined, so has the ability to guarantee flu vaccination doses for all who desire one. As it seems that the unpredictability of influenza vaccine supply is the main cause of the supply shortages, the main policy goal should be to bring back more manufacturers of flu vaccinations. Due to the lack of financial incentive to produce flu vaccinations in the U.S., policymakers must decide on a method of bringing more vaccinations to the U.S. from abroad or subsidizing the ones
Open Document